Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-21-022013
Filing Date
2021-04-29
Accepted
2021-04-29 16:34:52
Documents
5
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 DEF 14A eldn-def14a_20210615.htm DEF 14A 974861
2 GRAPHIC gijmaukbulmx000004.jpg GRAPHIC 54465
3 GRAPHIC gijmaukbulmx000003.jpg GRAPHIC 97436
4 GRAPHIC gijmaukbulmx000002.jpg GRAPHIC 12973
5 GRAPHIC gijmaukbulmx000001.jpg GRAPHIC 12973
  Complete submission text file 0001564590-21-022013.txt   1221613
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Eledon Pharmaceuticals, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36620 | Film No.: 21871293
SIC: 2834 Pharmaceutical Preparations